No Data
Roche Gets FDA Approval for Multiple-Sclerosis Treatment
Roche Group's Genentech Announces FDA Approves Ocrevus Zunovo As The First And Only Twice-A-Year 10-Minute Subcutaneous Injection For People With Relapsing And Progressive Multiple Sclerosis
AstraZeneca, Roche Cut at Deutsche After Trial Readouts for Key Drugs
Eli Lilly Wins Buy as Citi Resumes Coverage on Obesity Prospects
Roche Stock to Benefit From Accu-Chek Smartguide Launch in Europe
Roche Wins FDA Nod for Tecentriq Version Developed With Halozyme
No Data
No Data
